Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Xiao

Showing results (221-230 of 664) with videos related to

Pageof 67
Sort By:
Journal of Bone Oncology|July 3, 2025
Chondroblastoma of the femoral head:current and future therapeutic optionsJun Teng, Yitong Ding, Can Liu, et al.
Oncology Research|May 24, 2014
SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cellsKe Cao, Dingfang Xie, Peiguo Cao, et al.
Cell Communication and Signaling : CCS|February 28, 2024
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GISTShishan Zhou, Omar Abdihamid, Fengbo Tan, et al.
Heliyon|September 29, 2023
Curcumin reverses erastin-induced chondrocyte ferroptosis by upregulating Nrf2Yizhao Zhou, Zhen Jia, Jing Wang, et al.
Life Sciences|March 17, 2019
MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29Huimin Du, Qing Xu, Sheng Xiao, et al.
BMC Pediatrics|January 4, 2022
Synovial chondromatosis combine with synovial tuberculosis of knee joint: a case reportNan Zhou, Ke Fang, Djandan Tadum Arthur V, et al.
Human Pathology|January 23, 2026
CDK12 Paradox in Breast Cancer: Loss-of-Function Fusion and Oncogenic Amplification as Dual Therapeutic TargetsChunqing Yu, Fangfang Yao, Dongbing Li, et al.
American Journal of Cancer Research|July 19, 2016
BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibitionLifeng Yang, Juefeng Wan, Sheng Xiao, et al.
The Journal of Clinical Investigation|May 10, 2014
Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cellsDavid M Kofler, Alexander Marson, Margarita Dominguez-Villar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicitySatoshi Jodo, Vyankatesh J Pidiyar, Sheng Xiao, et al.
Pageof 67

Showing results (221-230 of 664) with videos related to

Sort By:
Pageof 67
Journal of Bone Oncology|July 3, 2025
Chondroblastoma of the femoral head:current and future therapeutic optionsJun Teng, Yitong Ding, Can Liu, et al.
Oncology Research|May 24, 2014
SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cellsKe Cao, Dingfang Xie, Peiguo Cao, et al.
Cell Communication and Signaling : CCS|February 28, 2024
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GISTShishan Zhou, Omar Abdihamid, Fengbo Tan, et al.
Heliyon|September 29, 2023
Curcumin reverses erastin-induced chondrocyte ferroptosis by upregulating Nrf2Yizhao Zhou, Zhen Jia, Jing Wang, et al.
Life Sciences|March 17, 2019
MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29Huimin Du, Qing Xu, Sheng Xiao, et al.
BMC Pediatrics|January 4, 2022
Synovial chondromatosis combine with synovial tuberculosis of knee joint: a case reportNan Zhou, Ke Fang, Djandan Tadum Arthur V, et al.
Human Pathology|January 23, 2026
CDK12 Paradox in Breast Cancer: Loss-of-Function Fusion and Oncogenic Amplification as Dual Therapeutic TargetsChunqing Yu, Fangfang Yao, Dongbing Li, et al.
American Journal of Cancer Research|July 19, 2016
BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibitionLifeng Yang, Juefeng Wan, Sheng Xiao, et al.
The Journal of Clinical Investigation|May 10, 2014
Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cellsDavid M Kofler, Alexander Marson, Margarita Dominguez-Villar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicitySatoshi Jodo, Vyankatesh J Pidiyar, Sheng Xiao, et al.
Pageof 67